M. Podgorniak

发表

BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.

R. Porcher, C. Lebbé, J. Tost, 2014, Melanoma research.

SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway

N. Varin‐Blank, H. Bruzzoni-Giovanelli, F. Calvo, 2003, Oncogene.

Discoidin domain receptors: A promising target in melanoma

C. Lebbé, R. Fridman, A. Sohail, 2019, Pigment cell & melanoma research.

Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy.

M. Toublanc, L. Boccon‐Gibod, V. Ravery, 1997, European urology.

Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes

N. Dumaz, N. Basset-Seguin, N. Scamuffa, 2010, PloS one.

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2.

G. Millot, C. Lebbé, S. Kellouche, 2009, Blood.

Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation.

C. Legrand, S. Kellouche, M. Hoylaerts, 2007, Experimental cell research.

Research of Epstein-Barr Virus Genome and Quantification of Viral Load in Algerian Frozen Tissue of Breast Cancer

I. Joab, M. Podgorniak, S. Mourah, 2015 .

Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol)

M. Mathieu, J. Peyrat, K. Takada, 2006, Journal of Virology.

Driver KIT mutations in melanoma cluster in four hotspots

C. Lebbé, N. Dumaz, A. Sadoux, 2015, Melanoma research.

Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL

H. Dombret, M. Lanotte, E. Ségal-Bendirdjian, 2006, Leukemia.

Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.

Y. Allory, A. De la taille, F. Calvo, 2010, The International journal of biological markers.

Identification of a Novel Biomarker Signature Associated with Risk for Bone Metastasis in Patients with Renal Cell Carcinoma

Y. Allory, A. De la taille, F. Calvo, 2010 .

EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma

C. Lebbé, N. Basset-Seguin, A. Janin, 2016, Experimental dermatology.

Characterization of in vitro culture of HIV-negative Kaposi’s sarcoma-derived cells. In vitro responses to alfa interferon

G. Millot, R. Berger, C. Lebbé, 1997, Archives of Dermatological Research.

Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.

C. Lebbé, F. Calvo, M. Podgorniak, 2007, Cancer research.

Decreased IL‐1β and TNFα secretion in long‐term bone marrow culture supernatant from Fanconi's anaemia patients

F. Calvo, G. Socié, E. Gluckman, 1996 .

Stromal cells from human benign prostate hyperplasia produce a growth‐inhibitory factor for LNCaP prostate cancer cells, identified as interleukin‐6

F. Fauvel-Lafève, G. Millot, P. de Cremoux, 1996, International journal of cancer.

EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression

C. Lebbé, F. Calvo, M. Podgorniak, 2012, BMC Cancer.

Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma.

C. Pellet, Y. Hamel, C. Lebbé, 2006, The Journal of investigative dermatology.

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

C. Lebbé, N. Dumaz, S. Dalle, 2019, Oncotarget.

EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2

R. Porcher, G. Millot, C. Lebbé, 2010, PloS one.

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma

C. Lebbé, N. Dumaz, Saliha Yahiaoui, 2016, Oncotarget.

Validation of a preclinical model for assessment of drug efficacy in melanoma

C. Lebbé, N. Dumaz, Saliha Yahiaoui, 2016, Oncotarget.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

R. Porcher, C. Lebbé, N. Basset-Seguin, 2009, Archives of dermatology.

Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.

R. Porcher, H. Dombret, P. Rousselot, 2009, The International journal of biological markers.

Quantification of VEGF Isoforms and VEGFR Transcripts by qRT-PCR and Their Significance in Acute Myeloid Leukemia

R. Porcher, H. Dombret, P. Rousselot, 2009 .

Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patients.

P. de Cremoux, F. Calvo, G. Socié, 1996, European journal of haematology.

EMMPRIN regulates β1 integrin‐mediated adhesion through Kindlin‐3 in human melanoma cells

U. Maskos, C. Lebbé, N. Setterblad, 2015, Experimental dermatology.

Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes

Fabien Calvo, M. Candeias, H. Bruzzoni-Giovanelli, 2010, Journal of experimental & clinical cancer research : CR.

BRAF mutation levels predict response to vemurafenib in metastatic melanoma

R. Porcher, C. Lebbé, J. Tost, 2014 .

A novel tumor suppressor function of Kindlin-3 in solid cancer

J. Soulier, A. Idbaih, C. Lebbé, 2014, Oncotarget.

A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling

C. Lebbé, N. Basset-Seguin, A. Janin, 2012, PloS one.

Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype

Mohamed Abdelkarim, Jean-Luc Poyet, J. Poyet, 2011, PloS one.

EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF

L. Perez-Cano, J. Fernández-Recio, U. Maskos, 2015, Oncotarget.

Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas

R. Porcher, O. Cussenot, Y. Allory, 2010, PloS one.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

R. Porcher, C. Lebbé, N. Basset-Seguin, 2009, Archives of dermatology.

Estramustine resistance correlates with tau over‐expression in human prostatic carcinoma cells

G. Millot, S. Sangrajrang, K. Tew, 1998, International journal of cancer.

Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor

C. Lebbé, J. Tost, A. How-Kit, 2017, ESMO Open.